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Human cystatin C (HCC) is a low molecular weight member of the cystatin family (type2). HCC
consists of 120 amino acids. Normally it is an inhibitor of cysteine proteases, but in pathological
conditions it forms amyloid ﬁbrils in brain arteries of young adults. An ‘aggregation-prone’ penta-
peptide (47LQVVR51) was located within the HCC sequence using AmylPred, an ‘aggregation-prone’
peptide prediction algorithm developed in our lab. This peptide was synthesized and self-assembled
into amyloid-like ﬁbrils in vitro, as electron microscopy, X-ray ﬁber diffraction, Attenuated Total
Reﬂectance Fourier-Transform Spectroscopy and Congo red staining studies reveal. Thus, the
47LQVVR51 peptide seems to have an important role in HCC ﬁbrillization.
 2014 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction Human cystatin C (HCC) is a low molecular weight proteinHuman cystatins are proteins that have the capacity to regulate
normal body processes and usually their down-regulation causes
several diseases [1]. The ﬁrst cystatin sequence determined was
that for a protein isolated from human urine, which was ﬁrst called
c-trace due to its electrophoretic mobility and it was later renamed
cystatin C [2]. Cystatins form a single chain ‘superfamily’ of revers-
ible inhibitors of cysteine proteases of the papain-like (C1) and
legumain-related (C13) families, which consists of three major
types, with proteins homologous in sequence [3]. These groups,
based on molecular organization, have different distributions in
an organism. It is obvious that evolutionary pressure has created
different branches of cystatins by duplication events far back in
time. Today, we know that cystatins are present in many kinds of
eukaryotic organisms such as mammals, birds, ﬁsh, insects, plants
and some protozoa [4]. The basic structural fold of monomeric
representatives of the cystatin superfamily has been deﬁned by
the crystal structure of chicken cystatin [5].which belongs to the cystatin family [6]. HCC, expressed in all
nucleated human cells, is a secretory type 2 cystatin, and it has,
predominantly, extracellular functions. It is widely used as an
endogenous marker of several illnesses since its presence in all
types of cells seems to be independent of age, sex andmuscle mass.
It is found in all tissues and body ﬂuids [4] and it is present at
particularly high concentrations in cerebrospinal ﬂuid [2,6]. It con-
sists of a polypeptide chain of 120 amino acid residues [3] and its
canonical structural features include a long alpha helix (a1 helix)
running across a large, ﬁve-stranded antiparallel beta-sheet
(Fig. 1). Recently, a monomer-stabilized HCC with an engineered
disulﬁde bond [(L47C)–(G69C)] has been created by Koladziejczyk
et al. [5]. Three regions are implicated in its interaction with the
enzyme papain family: The N-terminal segment and the two hair-
pin loops L1 and L2, constitute a structural epitope, which shows
high afﬁnity and binds to the enzyme [7] (Fig. 1).
HCC is co-deposited in the amyloid plaques of Alzheimer’s dis-
ease and Down’s syndrome [8] and it is also involved in tissue-
degenerative diseases such as osteoporosis and periodontosis [9].
In pathological processes, it forms amyloid deposits in brain arter-
ies of young adults, which lead to fatal cerebral hemorrhage. In
advanced age, under denaturing conditions the protein oligomeri-
zation leads to amyloid deposits in the leptomeninges, cerebral
cortex and brainstem [10]. These amyloid ﬁbrils are composed of
a mutated and truncated variant of cystatin C that eventually
Fig. 1. Amino acid sequence and native structure of human cystatin C. (A) The
polypeptide sequence normally consists of 120 amino acid residues [3]. In the case
of Cerebral Amyloid Angiopathy, proteolytic enzymes, which are present in the
cerebrospinal ﬂuid, remove the ﬁrst 10 amino acids, at the N-terminal of the native
sequence [14,17]. Predicted ‘aggregation-prone’ segments by AMYLPRED [28], are
shown in red (47LQVVR51) and bold (56IVAGVNYFLD65 and 95AFCSQIYAVP105),
respectively, and are marked with ‘‘#’’ under the sequence. Dark yellow lines point
out existing disulﬁde bonds. (B) A monomer-stabilized human cystatin C with an
engineered disulﬁde bond (see Section 1) is shown (PDB ID: 3GAX) [5], based on the
crystal structure of chicken cystatin [7]. L1 and L2 hairpin loops and the N-terminal
segment, indicate the structural epitope of the protein, capable of binding to
cysteine proteases. Colored regions in red and dark blue, illustrate the 47LQVVR51
‘aggregation-prone’ segment and Leucine 68, respectively.
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amyloidosis is called Hereditary Cystatin C Cerebral Amyloid Angi-
opathy (Icelandic Cerebral Angiopathy) and it seems to be the ﬁrst
familial type of amyloidosis related to a point mutation in a gene
coding for an inhibitor [11–13]. This angiopathy is an autosomal
dominant disorder found in members of 8 different families origi-
nating from one speciﬁc geographical area in Iceland [14,15].
Three crucial events turn the wild type protein into a patholog-
ical form. First, a point mutation (A? T) at codon 68 of cystatin C
gene (located on chromosome 20) converts a leucine to glutamine
(L68Q), leading at an amino acid substitution. Leucine 68 is located
at the C-terminal end of strand b3 and its side-chain participates in
the hydrophobic core that stabilizes the protein, between the
a-helix and the ﬁve-stranded b-sheet [16] (Fig. 1). In the case of
the mutant L68Q, the amino acid substitution affects greatly the
stability of the molecule, because the long polar side chain of
glutamine cannot be accommodated into the hydrophobic core of
HCC (Figs. 1 and S1). Secondly, human amyloid deposits have an
N-terminal truncation possibly because of the disintegration of
the leucocytes, normally present in the cerebrospinal ﬂuid. Proteo-
lytic enzymes take action and remove the ﬁrst 10 amino acids
residues of the native sequence of HCC [14,17]. Finally, replace-
ment of the hydrophobic Leu68 promotes unfolding through the
L1 loop with a speciﬁc mechanism named 3D-domain swapping
[18] (Supplementary Fig. S1). From the time of its deﬁnition it
has been observed in different proteins; among them in the amy-
loidogenic proteins prion and b2-microglobulin [19,20].
In the case of cystatin C, the L1 loop is the segment of the pro-
tein, which connects the swapped domain to the rest of the protein
and actually the one segment which changes its conformation
between the monomer and the oligomer. Two identical monomers
exchange equivalent structural components and form a closed
interface, which is identical in the monomer and dimer, with the
exception that in the oligomer two separate polypeptide chains
contribute to the interaction [19] (Supplementary Fig. S1). This
mechanism for protein homo-oligomerization may be involved in
the ﬁbrillogenesis in the case of angiopathy [17].
Amyloids are formed under protein-denaturing conditions or as
a result of mutations, as in HCC. The conversion of amyloidogenic
proteins from their soluble forms into ﬁbrillar aggregates is associ-
ated with a wide range of pathological conditions [21–24]. As
research continues for the understanding of the mechanisms
involved in amyloid formation, the development of prediction
methods is an important complement to experimental approaches
[23]. Detailed theoretical and experimental evidence has repeat-
edly indicated that amyloid formation is mediated by speciﬁc short
sequence regions/stretches of a polypeptide chain that have a
higher aggregation propensity and therefore vitally contribute to
its aggregation tendency [25–27]. In this work, we determined a
novel aggregation-potent segment of HCC, 47LQVVR51, which was
initially predicted as such, by implementing AMYLPRED, our aggre-
gation propensity prediction algorithm [28]. This ‘aggregation-
prone’ peptide segment was synthesized (see Section 2) and here
we present experimental results, verifying its strong aggregation
propensity to form amyloid ﬁbrils. Also, we discuss our ﬁndings,
implicating LQVVR as one of the main the driving forces in HCC
ﬁbril formation, providing a novel target for HCC amyloidoses
prevention/prohibition.2. Materials and methods
2.1. Peptide synthesis and formation of amyloid-like ﬁbrils
The LQVVRpeptide-analogue, part of the 2ndbeta-strand of cyst-
atin C (Fig. 1) was synthesized by GeneCust Europe, Luxembourg(98% pure, free N- and C-terminals). The synthesized LQVVR peptide
was dissolved in distilled water (pH 5.5), at a concentration of
10 mg/ml to produce mature amyloid-like ﬁbrils after 1–2 weeks
incubation. Oriented ﬁbers, suitable for X-ray diffraction, were
obtained from suspensions of LQVVR mature amyloid-like ﬁbrils,
as described below.
2.2. X-ray diffraction
A droplet (10 ll) of mature ﬁbril suspension was placed
between two siliconized glass rods, spaced 1.5 mm apart and
mounted horizontally on a glass substrate, as collinearly as possi-
ble. The droplet was allowed to dry slowly at ambient temperature
and humidity for 1 h to form an oriented ﬁber, suitable for X-ray
diffraction. X-ray diffraction patterns were recorded on a Mar
Research 345 mm image plate, utilizing CuKa radiation (k =
1.5418 Å), obtained from a Rigaku MicroMax-007 HF, microfocus
rotating anode generator (with Osmic Rigaku VariMax™ HF
optics), operated at 40 kV, 20 mA. The specimen-to-ﬁlm distance
was set at 150 mm and the exposure time was 30 min. No
additional low angle reﬂections were observed at longer speci-
men-to-ﬁlm distances, up to 300 mm. The X-ray patterns, initially
viewed using the program MarView (MAR Research, Hamburg,
Germany), were displayed and measured with the aid of the
program IPDISP of the CCP4 package [29].
Fig. 2. Transmission electron microscopy images of negatively stained LQVVR
amyloid-like ﬁbrils, forming ribbons (see Section 3). Individual ﬁbrils are indicated
with multiple black arrows (ca. 30–40 Å in diameter). Bar is 200 nm.
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For negative staining, LQVVR peptide mature ﬁbril suspensions
were applied to glow-discharged 400-mesh carbon-coated copper
grids for 60 s. The grids were (occasionally) ﬂash-washed with
150 ll of distilled water and stained with a drop of 1% (w/v)
aqueous uranyl acetate for 45 s. Excess stain was removed by
blotting with a ﬁlter paper and the grids were air-dried. They
were examined in a Philips CM120 BioTWIN transmission electron
microscope (FEI, Eindhoven, The Netherlands) operated at 100 kV.
Photographs were obtained with a bottom-mounted Keen View 1K
CCD camera (Soft Imaging System, Muenster, Germany).
2.4. Attenuated total reﬂectance Fourier-transform infrared
spectroscopy (ATR FT-IR) and post-run computations of the spectra
A 10-ll drop of the HCC-analogue, LQVVR, mature ﬁbril suspen-
sion was cast on a front-coated Au mirror and left to dry slowly at
ambient conditions to form a thin ﬁlm. Infrared spectra were
obtained from these ﬁlms at a resolution of 4 cm1, utilizing an
IR microscope (IRScope II by Bruker Optics) equipped with a Ge
attenuated total reﬂectance (ATR) objective lens (20) and
attached to a Fourier-transform infrared (FTIR) spectrometer
(Equinox 55, by Bruker Optics). Internal reﬂection spectroscopy
has several advantages compared with the more common KBr dis-
persion technique [30]. The choice of ATR was dictated by the need
to exclude any possible spectroscopic and chemical interactions
between the sample and the dispersing medium. Having a penetra-
tion depth ca. 1–2 lm (1000 cm1, Ge), ATR is free of saturation
effects, which may be present in the transmission spectra of
thicker samples. Moreover, the use of a microscope facilitates the
acquisition of data from small samples. Ten 32-scan spectra were
collected from each sample and averaged to improve the S/N ratio.
The spectra are shown in the absorption mode after correction for
the wavelength dependence of the penetration depth (pd  k).
Absorption band maxima were determined from the minima in
the second derivative of the corresponding spectra. Derivatives
were computed analytically using routines of the Bruker OPUS/
OS2 software and included smoothing by the Savitzky–Golay
algorithm [31] over a ±8 cm1 range, around each data point.
Smoothing over narrower ranges resulted in a deterioration of
the S/N ratio and did not increase the number of minima that could
be determined with conﬁdence.
2.5. Congo red staining and polarized light microscopy
HCC mature ﬁbril suspensions were applied to glass slides and
stained with a 10 mM Congo Red (Sigma) solution in PBS
(phosphate-buffered saline, pH 7.4) for approximately 30 min.
Then, they were washed several times with 90% ethanol and left
to dry approximately for 10 min. The samples were observed under
bright ﬁeld illumination and between cross polars, using a Leica
MZ75 polarizing stereomicroscope, equipped with a JVC GC-X3E
camera.
2.6. Crystallization experiments and polarized light microscopy
Quantities of freshly made LQVVR peptide solutions in distilled
water (concentrations 5–10 mg/ml, pH 5.5) were tested in crystal-
lization experiments, using the ‘‘hanging-drop’’ method [32], for
the possible formation of crystals. The precipitant was (NH4)2SO4
(concentration varied from 1.0 to 2.0 M). The samples were
observed, both under bright ﬁeld illumination and between
crossed polars, respectively, using a Leica MZ75 polarizing stereo-
microscope (please, see Supplementary Data).2.7. Structural models
The HCC models were built from PDB ﬁles 3GAX, 1R4C and
1G96 [33]. The software PyMol [34] was used to visualize and
manipulate the models.
3. Results
Electron micrographs of LQVVR peptide ﬁbrils show protoﬁla-
ments, which are straight, unbranched and coalesce laterally
among each other to form ribbons (or tapes). The protoﬁlaments
have a diameter of approximately 30 Å (Fig. 2). Congo red stained
LQVVR peptide ﬁbrils showed the red–green birefringence charac-
teristic of amyloid ﬁbrils, when viewed under crossed polars
(Fig. 3). Additionally, X-ray diffraction patterns from ﬁbers formed
from LQVVR peptide ﬁbrils showed two strong reﬂections at 4.62 Å
and 11.63 Å (Fig. 4). These reﬂections appear as rings due to the
poor alignment of the constituent ﬁbrils. This is probably due to
random packing of the ﬁbers in the gels which adopt all possible
orientations as conﬁrmed by electron microscopy. The strong
reﬂection at 4.62 Å suggests that b-sheets are present and it is
attributed to inter-strand distances. The weaker reﬂection at
11.63 Å most probably corresponds to the inter-sheet packing
distances. These two reﬂections clearly indicate the existence of
b-sheets and are characteristic of the cross-b conformation
observed for several amyloid-like ﬁbrils (Fig. 4), not oriented,
however, in this case. The ATR FT-IR spectrum (Fig. 5) shows a
prominent band at 1634 cm1 in the amide I region, which is a
band clearly due to b-sheet conformation and the shoulder at
1697 cm1 is an indication that the b-sheets are antiparallel
[35–39]. Thus, this spectrum supports the presence of antiparallel
b-sheets in the structure of the LQVVR peptide ﬁbrils, apparently in
agreement with the existence of b-sheet structure suggested by
X- ray diffraction and Congo red binding data (Table 1).
4. Discussion
Our experimental work clearly shows that ﬁbrils formed from
LQVVR peptide solutions fulﬁll all three basic criteria of amyloid
ﬁbrils: they are straight and unbranched, they bind the dye Congo
Red exhibiting the characteristic for amyloids ‘red-apple/green’
birefringence, and oriented ﬁbers made-up of them give character-
istic ‘cross-b’ – like X-ray diffraction patterns [24].
Several ﬁbrillogenesis pathways of peptides or proteins have
been proposed during the last two decades and many concepts
have been described for the in vitro or in vivo formation of amyloid
Fig. 3. A 10 mg/ml solution of the LQVVR peptide was incubated in distilled water
(at ambient temperatures, pH 5.5), for approximately 10 days to produce mature
amyloid-like ﬁbrils and then it was stained with Congo Red. Mature amyloid-like
ﬁbrils appear red under bright ﬁeld illumination and exhibit a strong green-apple
birefringence under crossed polars. Bar is 500 lm.
Fig. 4. X-ray diffraction pattern from aligned LQVVR peptide mature amyloid-like
ﬁbrils. Reﬂections with spacings of 4.62 Å and 11.63 Å, respectively, are indicated
with arrows. Diffraction patterns were acquired using a Rigaku MicroMax-007
microfocus rotating anode generator (with Osmic Rigaku VariMax™ HF optics),
operated at 40 kV, 20 mA.
Fig. 5. ATR FT-IR (1100–1800 cm1) spectrum of LQVVR peptide mature amyloid
ﬁbrils, cast on a ﬂat stainless-steel plate and left to air-dry slowly, at ambient
conditions, to form a hydrated, thin ﬁlm. A second derivative spectrum is also
included.
Table 1
Bands observed in the ATR FT-IR (1500–1800 cm1) spectrum produced from a
hydrated ﬁlm of the ‘aggregation-prone’ pentapeptide, LQVVR, after self-
assembly, and their tentative assignments (Fig. 5).
Band (cm1) Assignment
1135 TFA
1200 TFA
1234 Amide III (b-sheet)
1391
1551 Amide II (b-sheet)
1634 Amide I (b-sheet)
1663 TFA
1697 Amide I (antiparallel b-sheet)
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tures, known as spherulites were formed after 1 day incubation of
LQVVR under a wide variety of conditions (Supplementary Fig. S2).
As we have proposed in 2004 [44] the ﬁrst main step of amyloid-
like ﬁbrillogenesis is the formation of a nuclei of liquid crystalline
nature, in several cases. Spherulites were observed in a polarizing
microscope under crossed polars with characteristic ‘maltese
crosses’ [45,46]. In a similar fashion we might assume that these
liquid crystalline intermediates of LQVVR were transformed into
amyloid-like ﬁbrils (Supplementary Fig. S2). Electron micrographs
of mature ﬁbrils, obtained from solutions of the LQVVR peptide,
after 1–2 weeks incubation, show protoﬁlaments associated later-
ally to form multistranded ribbons (or tapes). The protoﬁlaments
have a thickness of approximately 30 Å, almost at the resolution
limit of the electron microscope (Fig. 2).
The propensity of the wild type (wt) HCC and of the mutated
form L68Q to form ﬁbrils in vitro were tested by Wahlbom et al.[47]. The wt protein forms long, twisted ﬁbrils with a diameter
of 100–120 Å, at pH 4, whereas the mutated protein forms ﬁbrils
with the same appearance to those of the wt protein, but with a
higher tendency for lateral attachment.
Amyloid aggregation is actually driven by short fragments of
misfolded proteins (‘‘amyloid stretch hypothesis’’) [25–27]. Short
amyloidogenic stretches of ﬁve or six amino acid residues provide
the potential to ‘guide’ amyloid ﬁbril formation from a soluble
globular domain. Therefore, several algorithms have been
published during the last decade or so, which attempt to predict
such ‘aggregation-prone’ stretches based on various properties of
peptide chains. A relatively recent review of available software is
given in Ref. [23]. Utilizing our consensus prediction algorithm of
‘aggregation-prone’ segments AMYLPRED [28], three (3) peptides
of HCC were predicted as ‘aggregation-prone’ segments: The
Fig. 6. Crystal structure of the domain swapped octamer of N-truncated HCC (PDB ID: 1R4C). Two tetramers interact together via two LQVVR pentapeptides (in red) to form
an octamer. Red sticks represent the atomic structure of the LQVVR peptide, both backbone and side chains. A dashed line connects the main chain carbonyl O atom (bright
red) of Leu 47 (chain H) and the main chain N atom (blue) of Val49 (chain A), indicating a possible hydrogen bond between the two donut shaped tetramers.
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95AFCSFQIYAVP105 (Fig. 1). All three peptides were synthesized
and the LQVVR peptide was shown conclusively to have amyloido-
genic properties (see Section 3), whereas for the other two
peptides work is in progress to determine their amyloidogenic
properties (data in preparation).
Amyloid deposits of patients in cerebrospinal ﬂuid contain HCC,
shortened by ten amino acid residues at the N-terminal segment
because of disintegration of proteolytic leucocyte enzymes, which
are normally present in this ﬂuid [17]. Janowski et al. [17] managed
to crystallize this N-truncated form of HCC and solve its crystal
structure (PDB ID 1R4C). They discovered that this form of HCC
forms domain swapped dimers of HCC (Supplementary Fig. S1),
which in turn form tetramers and the tetramers in turn associate
to form octamers (Fig. 6). It was very interesting to note that tetra-
mers interact via the highly amyloidogenic LQVVR peptide to form
octamers (Fig. 6). It is noteworthy that the ‘aggregation-prone’
peptide LQVVR lies exposed on the surface of the tetramers and
promotes their interaction for the formation of octamers, as has
been suggested by Frousios et al. [28]. At the same time, our results
indeed support the idea that protein–protein interaction surfaces
and ‘aggregation-prone’ segments overlap in the homooligomeric
form of proteins [46], since LQVVR is both a peptide with high
aggregation propensity and a crystal contact [48].
In analogy to the model proposed by Staniforth et al. [49], based
on the amyloidogenic properties of the peptide LQVVR and on the
packing observed in the crystal structure 1R4C [17], we propose
the model shown in Supplementary Fig. S3 as a plausible model
of the amyloid ﬁbrils formed by HCC. These ﬁbrils have a diameter
ca. 90–100 Å.
In this respect, it is interesting to note that, recent studies cre-
ated a stabilized monomer of HCC using an engineered disulﬁde
bond (L47C)–(G69C) between the structural elements that become
separated upon domain swapping. Apart from the two well-
conserved disulﬁde bridges of HCC which support the folding of
the monomer, crystallographers created a brand new monomer-
stabilizing disulﬁde bridge. They found that it is possible to inhibit
dimerization, further oligomerization and ﬁnally amyloid forma-
tion of HCC by site-directed mutagenesis of its sequence. One of
the mutant amino acids was Leu47 which is part of 47LQVVR51 [5].
For Icelandic Cerebral Angiopathy treatment, remedies/drugs
designed to prevent aggregation of the LQVVR peptide, may prove
to be of paramount importance in future work, following the exam-
ple of recent impressive studies on transthyretin amyloidosis [50].Notes
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